S&P 500
5,888.55
-0.6%
-$32.99
DJI
42,098.70
-0.6%
-$244.95
NASDAQ
19,100.94
-0.5%
-$98.23
Bitcoin
107,873.00
-0.9%
-989.23
AAPL
$200.40
+0.1%
+$0.19
AMZN
$204.64
-0.7%
-$1.38
GOOG
$173.28
-0.4%
-$0.70
META
$643.48
+0.2%
+$1.16
MSFT
$457.40
-0.7%
-$3.28
NVDA
$135.14
-0.3%
-$0.36
TSLA
$356.97
-1.6%
-$5.92
FluoroPharma Medical (OTC: FPMI)
$0.00
(0.0%)
$0.00
Price as of April 29, 2025, 9:32 a.m. ET
FluoroPharma Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
FluoroPharma Medical Company Info
FluoroPharma Medical, Inc. is a molecular imaging company, which engages in the research, development, and commercialization molecular imaging pharmaceuticals with initial applications in the area of cardiology. It focuses on the development of breakthrough positron emission tomography imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease. The company was founded on January 25, 2007 and is headquartered in Montclair, NJ.
News & Analysis
No articles found.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.